Fingerprint
Dive into the research topics of 'Temozolomide as second or third line treatment of patients with neuroendocrine carcinomas'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Temozolomide as second or third line treatment of patients with neuroendocrine carcinomas
Ingrid Marie Holst Olsen, Jens B Sørensen, Birgitte Federspiel, Andreas Kjaer, Carsten P Hansen, Ulrich Knigge, Seppo W Langer